title: Utility of Cancer Value Frameworks for Patients, Payers, and Physicians.
authors.affiliation: Harvard University, Cambridge, Massachusetts.
authors.forename: Amitabh
authors.initials: A
authors.lastname: Chandra
authors.affiliation: Precision Health Economics, Los Angeles, California.
authors.forename: Jason
authors.initials: J
authors.lastname: Shafrin
authors.affiliation: Merck, Kenilworth, New Jersey.
authors.forename: Ravinder
authors.initials: R
authors.lastname: Dhawan
mesh_terms: D003362:Cost-Benefit Analysis; D018572:Disease-Free Survival; D005382:Financing, Personal; D017048:Health Care Costs; D006801:Humans; D007349:Insurance, Health, Reimbursement; D009369:Neoplasms / Q000191:economics / Q000628:therapy*; D009938:Organizations; D010043:Outcome and Process Assessment, Health Care; D061214:Patient Safety; D016032:Randomized Controlled Trials as Topic / Q000592:standards; D016019:Survival Analysis